Forest Laboratories, Inc. (NYSE:FRX)
| CAPS Rating |
|
|---|---|
| Open | $31.37 |
| Previous Close | $31.53 |
| Daily Range | $31.16 - $31.56 |
| 52-Week Range | $28.47 - $40.52 |
| Market Cap | $8.66B |
| P/E Ratio | 7.80 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,306,290 |
| Average Daily Volume | 0 |
How do you think FRX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
FRX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
FRX News and Commentary
- Positive Results on Forest/Gedeon Drug - Analyst Blog – NASDAQ
- The Zacks Analyst Blog Highlights: Citigroup, JPMorgan Chase, Goldman Sachs Group, Bank of America a – NASDAQ
- Forest Laboratories Beats Analyst Estimates on EPS – The Motley Fool
- Forest Beats, Ups View - Analyst Blog – NASDAQ
- Opening View: DJIA Pointed Higher on China GDP; Financials in the Earnings Spotlight – NASDAQ
- Earnings Preview: Forest Labs - Analyst Blog – NASDAQ
- Something to Watch at Forest Laboratories – The Motley Fool
- Ring in Generics in 2012 and Beyond - Analyst Blog – NASDAQ
- Teva Provides In-Line 2012 Outlook - Analyst Blog – NASDAQ
- UPDATE: Teva Sees Sales, Profit Up In 2012; Authorizes $3 Billion Stock Buyback – SmartMoney
- Teva Sees Sales, Profit Up In 2012; Authorizes $3 Billion Stock Buyback – SmartMoney
- Zacks Bull and Bear of the Day Highlights: Smithfield Food, BHP Billiton, Pfizer, Eli Lilly and Fore – NASDAQ
- Positive Data on Pfizer's Lyrica - Analyst Blog – NASDAQ
- The Zacks Analyst Blog Highlights: Pfizer, Bristol - Myers Squibb, Eli Lilly, Forest Laboratories an – NASDAQ
- Emerging Markets: The Way Forward - Analyst Blog – NASDAQ
- Does Elan Miss the Grade? – The Motley Fool
- Magic Formula Investing Weekly Roundup 11/20/11 – Blog at The Motley Fool
- AstraZeneca, Forest Enter Superbug Combo In Late Stage Trials – SmartMoney
- FRX 2Q Earnings Alert: Thomson Reuters 99 Cents – SmartMoney
- Don't Get Too Worked Up Over Forest Laboratories' Latest Numbers – The Motley Fool

RSS Headlines
Fool UK